Testolactone

CAS No. 968-93-4

Testolactone( —— )

Catalog No. M22381 CAS No. 968-93-4

Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 159 In Stock
5MG 238 In Stock
10MG 398 In Stock
25MG 588 In Stock
50MG 900 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Testolactone
  • Note
    Research use only, not for human use.
  • Brief Description
    Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?
  • Description
    Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Aromatase
  • Recptor
    aromatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    968-93-4
  • Formula Weight
    300.39
  • Molecular Formula
    C19H24O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cummings E A , Salisbury S R , Givner M L , et al. Testolactone-Associated High Androgen Levels, a Pharmacologic Effect or a Laboratory Artifact? 1[J]. Journal of Clinical Endocrinology & Metabolism, 1998, 83(3):784-787.
molnova catalog
related products
  • Exemestane

    Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast Y in postmenopausal women.

  • Flavokawain A

    Flavokawain A has anti-tumor activity, such as inhibits growth of bladder tumor cells in a nude mice model , prevents the recurrence and progression of non-muscle-invasive urothelial cell carcinoma.

  • 3,4-Dimethoxyhydroci...

    It is an organic compunds with molecular fomula C11H14O4.